当前位置： SCI文献检索 > Molecular Cancer期刊下所有文献 > The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.

The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.

Abstract：

BACKGROUND:In recent years, circular RNAs (circRNAs), a new star of non-coding RNA, have been emerged as vital regulators and gained much attention for involvement of initiation and progression of diverse kinds of human diseases, especially cancer. However, regulatory role, clinical significance and underlying mechanisms of circRNAs in triple-negative breast cancer (TNBC) still remain largely unknown. METHODS:Here, the expression profile of circRNAs in 4 pairs of TNBC tissues and adjacent non-tumor tissues was analyzed by RNA-sequencing. Quantitative real-time PCR and in situ hybridization were used to determine the level and prognostic values of circAGFG1 in two TNBC cohorts. Then, functional experiments in vitro and in vivo were performed to investigate the effects of circAGFG1 on tumor growth and metastasis in TNBC. Mechanistically, fluorescent in situ hybridization, dual luciferase reporter assay, RNA pull-down and RNA immunoprecipitation experiments were performed to confirm the interaction between circAGFG1 and miR-195-5p in TNBC. RESULTS:We found that circAGFG1 was evidently up-regulated in TNBC, and its level was correlated with clinical stage, pathological grade and poor prognosis of patients with TNBC. The results indicated that circAGFG1 could promote TNBC cell proliferation, mobility and invasion as well as tumorigenesis and metastasis in vivo. Mechanistic analysis showed that circAGFG1 may act as a ceRNA (competing endogenous RNA) of miR-195-5p to relieve the repressive effect of miR-195-5p on its target cyclin E1 (CCNE1). CONCLUSIONS:Our findings suggest that circAGFG1 promotes TNBC progression through circAGFG1/miR-195-5p/CCNE1 axis and it may serve as a new diagnostic marker or target for treatment of TNBC patients.

journal_name

Mol Cancer

journal_title

Molecular cancer

authors

Yang R,Xing L,Zheng X,Sun Y,Wang X,Chen J

doi

10.1186/s12943-018-0933-7

subject

Has Abstract

pub_date

2019-01-08 00:00:00

pages

4

issue

1

issn

1476-4598

pii

10.1186/s12943-018-0933-7

journal_volume

18

pub_type

杂志文章

相关文献

Molecular Cancer文献大全
  • Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo.

    abstract：BACKGROUND:Constitutive activation of signal transducer and activator of transcription 3 (STAT3) has been linked with proliferation, survival, invasion and angiogenesis of a variety of human cancer cells, including hepatocellular carcinoma (HCC). Thus, novel agents that can suppress STAT3 activation have potential for ...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-13-66

    authors： Sethi G,Chatterjee S,Rajendran P,Li F,Shanmugam MK,Wong KF,Kumar AP,Senapati P,Behera AK,Hui KM,Basha J,Natesh N,Luk JM,Kundu TK

    更新日期：2014-03-21 00:00:00

  • Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells.

    abstract：BACKGROUND:Sharing the common neuroectodermal origin, melanoma and neuroblastoma are tumors widely diffused among adult and children, respectively. Clinical prognosis of aggressive neuroectodermal cancers remains dismal, therefore the search for novel therapies against such tumors is warranted. Curcumin is a phytochemi...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-9-137

    authors： Pisano M,Pagnan G,Dettori MA,Cossu S,Caffa I,Sassu I,Emionite L,Fabbri D,Cilli M,Pastorino F,Palmieri G,Delogu G,Ponzoni M,Rozzo C

    更新日期：2010-06-03 00:00:00

  • Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p.

    abstract：BACKGROUND:Although gemcitabine-based chemotherapy has been established as a core multimodal therapy for non-small cell lung cancer (NSCLC) treatment, its clinical efficacy remains limited by the development of acquired resistance following tumor metastasis and relapse. In this study, we investigated how gemcitabine-re...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-017-0694-8

    authors： Wei F,Ma C,Zhou T,Dong X,Luo Q,Geng L,Ding L,Zhang Y,Zhang L,Li N,Li Y,Liu Y

    更新日期：2017-07-25 00:00:00

  • Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo.

    abstract：:The mammalian target of rapamycin (mTOR), which exists in two functionally distinct complexes, mTORC1 and mTORC2 plays an important role in tumor growth. Whereas the role of mTORC1 has been well characterized in this process, little is known about the functions of mTORC2 in cancer progression. In this study, we explor...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-9-57

    authors： Roulin D,Cerantola Y,Dormond-Meuwly A,Demartines N,Dormond O

    更新日期：2010-03-12 00:00:00

  • Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo.

    abstract：BACKGROUND:Differential mRNA splicing and alternative promoter usage of the TP73 gene results in the expression of multiple NH2-truncated isoforms that act as oncogenes. Abundant levels of these p73 variants in a variety of human cancers correlated with adverse clinical prognosis and response failure to conventional th...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-8-61

    authors： Emmrich S,Wang W,John K,Li W,Pützer BM

    更新日期：2009-08-11 00:00:00

  • PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.

    abstract：BACKGROUND:Glioblastomas (GBM) continue to remain one of the most dreaded tumours that are highly infiltrative in nature and easily preclude comprehensive surgical resection. GBMs pose an intricate etiology as they are being associated with a plethora of genetic and epigenetic lesions. Misregulation of the PI3 kinase p...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-016-0557-8

    authors： Nawaz Z,Patil V,Paul Y,Hegde AS,Arivazhagan A,Santosh V,Somasundaram K

    更新日期：2016-11-21 00:00:00

  • KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancer.

    abstract：BACKGROUND:Lung cancer in nonsmokers tends to be driven by a single somatic mutation or a gene fusion. KIF5B-RET fusion is an oncogene identified in non-small cell lung cancers. In this study, we verified the oncogenic activity of KIF5B-RET fusion and investigated how KIF5B-RET activates the specific signaling pathways...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-13-176

    authors： Qian Y,Chai S,Liang Z,Wang Y,Zhou Y,Xu X,Zhang C,Zhang M,Si J,Huang F,Huang Z,Hong W,Wang K

    更新日期：2014-07-21 00:00:00

  • Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A.

    abstract：BACKGROUND:Most ovarian cancers are highly invasive in nature and the high burden of metastatic disease make them a leading cause of mortality among all gynaecological malignancies. The homeodomain transcription factor, PITX2 is associated with cancer in different tissues. Our previous studies demonstrated increased PI...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-015-0433-y

    authors： Basu M,Bhattacharya R,Ray U,Mukhopadhyay S,Chatterjee U,Roy SS

    更新日期：2015-08-23 00:00:00

  • Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells.

    abstract：BACKGROUND:Truncated dopamine and cyclic-AMP-regulated phosphoprotein (t-DARPP) is frequently overexpressed in gastrointestinal malignancies. In this study, we examined the role of t-DARPP in regulating β-catenin. RESULTS:The pTopFlash construct that contains multiple TCF/LEF-binding sites was used as a measure of β-c...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-10-32

    authors： Vangamudi B,Zhu S,Soutto M,Belkhiri A,El-Rifai W

    更新日期：2011-03-29 00:00:00

  • Oncogenic KRAS promotes malignant brain tumors in zebrafish.

    abstract：BACKGROUND:Zebrafish have been used as a vertebrate model to study human cancers such as melanoma, rhabdomyosarcoma, liver cancer, and leukemia as well as for high-throughput screening of small molecules of therapeutic value. However, they are just emerging as a model for human brain tumors, which are among the most de...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-015-0288-2

    authors： Ju B,Chen W,Orr BA,Spitsbergen JM,Jia S,Eden CJ,Henson HE,Taylor MR

    更新日期：2015-02-03 00:00:00

  • Effects of tumor metabolic microenvironment on regulatory T cells.

    abstract：:Recent studies have shown that on one hand, tumors need to obtain a sufficient energy supply, and on the other hand they must evade the body's immune surveillance. Because of their metabolic reprogramming characteristics, tumors can modify the physicochemical properties of the microenvironment, which in turn affects t...

    journal_title：Molecular cancer

    pub_type： 杂志文章,评审

    doi：10.1186/s12943-018-0913-y

    authors： Wang YA,Li XL,Mo YZ,Fan CM,Tang L,Xiong F,Guo C,Xiang B,Zhou M,Ma J,Huang X,Wu X,Li Y,Li GY,Zeng ZY,Xiong W

    更新日期：2018-11-26 00:00:00

  • Liquid biomarkers in melanoma: detection and discovery.

    abstract：:A vast array of tumor-derived genetic, proteomic and cellular components are constantly released into the circulation of cancer patients. These molecules including circulating tumor DNA and RNA, proteins, tumor and immune cells are emerging as convenient and accurate liquid biomarkers of cancer. Circulating cancer bio...

    journal_title：Molecular cancer

    pub_type： 杂志文章,评审

    doi：10.1186/s12943-018-0757-5

    authors： Lim SY,Lee JH,Diefenbach RJ,Kefford RF,Rizos H

    更新日期：2018-01-17 00:00:00

  • Epigenetic aberrations and cancer.

    abstract：:The correlation between epigenetic aberrations and disease underscores the importance of epigenetic mechanisms. Here, we review recent findings regarding chromatin modifications and their relevance to cancer. ...

    journal_title：Molecular cancer

    pub_type： 杂志文章,评审

    doi：10.1186/1476-4598-5-60

    authors： Ducasse M,Brown MA

    更新日期：2006-11-08 00:00:00

  • DNA-dependent protein kinase catalytic subunit (DNA-PKcs)-SIN1 association mediates ultraviolet B (UVB)-induced Akt Ser-473 phosphorylation and skin cell survival.

    abstract：BACKGROUND:The exposure of skin keratinocytes to Ultraviolet (UV) irradiation leads to Akt phosphorylation at Ser-473, which is important for the carcinogenic effects of excessive sun exposure. The present study investigated the underlying mechanism of Akt Ser-473 phosphorylation by UVB radiation. RESULTS:We found tha...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-12-172

    authors： Tu Y,Ji C,Yang B,Yang Z,Gu H,Lu CC,Wang R,Su ZL,Chen B,Sun WL,Xia JP,Bi ZG,He L

    更新日期：2013-12-24 00:00:00

  • Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer.

    abstract：BACKGROUND:New therapies are urgently needed for patients with small cell lung cancer (SCLC). Chemotherapy and targeted therapies, including the Bcl-2 inhibitor ABT-737, may induce tumor cell autophagy. Autophagy can promote survival of cancer cells under stress and comprise a pathway of escape from cytotoxic therapies...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-12-16

    authors： Zinn RL,Gardner EE,Dobromilskaya I,Murphy S,Marchionni L,Hann CL,Rudin CM

    更新日期：2013-03-02 00:00:00

  • m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer.

    abstract：BACKGROUND:The epigenetic regulation of immune response has been demonstrated in recent studies. Nonetheless, potential roles of RNA N6-methyladenosine (m6A) modification in tumor microenvironment (TME) cell infiltration remain unknown. METHODS:We comprehensively evaluated the m6A modification patterns of 1938 gastric...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-020-01170-0

    authors： Zhang B,Wu Q,Li B,Wang D,Wang L,Zhou YL

    更新日期：2020-03-12 00:00:00

  • Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma.

    abstract：BACKGROUND:Pancreatic acinar cell carcinoma (ACC) is a rare tumor entity with an unfavorable prognosis. Recent whole-exome sequencing identified p53 mutations in a subset of human ACC. Activation of the mammalian target of rapamycin (mTOR) pathway is associated with various pancreatic neoplasms. We thus aimed at analyz...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-015-0483-1

    authors： Kong B,Cheng T,Qian C,Wu W,Steiger K,Cao J,Schlitter AM,Regel I,Raulefs S,Friess H,Erkan M,Esposito I,Kleeff J,Michalski CW

    更新日期：2015-12-18 00:00:00

  • The Bcl-2/xL inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein in hepatocellular carcinoma cells.

    abstract：BACKGROUND:Hepatocellular carcinoma (HCC) is one of the major causes of mortality. ABT-263 is a newly synthesized, orally available Bcl-2/xL inhibitor that shows promising efficacy in HCC therapy. ABT-263 inhibits the anti-apoptotic activity of Bcl-2 and Bcl-xL, but not Mcl-1. Previous reports have shown that ABT-263 u...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-13-98

    authors： Wang B,Ni Z,Dai X,Qin L,Li X,Xu L,Lian J,He F

    更新日期：2014-04-30 00:00:00

  • Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling.

    abstract：BACKGROUND:Head and neck squamous cell carcinoma (HNSCC) is a highly lethal cancer that contains cellular and functional heterogeneity. Previously, we enriched a subpopulation of highly tumorigenic head and neck cancer initiating cells (HN-CICs) from HNSCC. However, the molecular mechanisms by which to govern the chara...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-9-283

    authors： Wu MJ,Jan CI,Tsay YG,Yu YH,Huang CY,Lin SC,Liu CJ,Chen YS,Lo JF,Yu CC

    更新日期：2010-10-27 00:00:00

  • mRNA-to-protein translation in hypoxia.

    abstract：:Cells respond to hypoxia by shifting cellular processes from general housekeeping functions to activating specialized hypoxia-response pathways. Oxygen plays an important role in generating ATP to maintain a productive rate of protein synthesis in normoxia. In hypoxia, the rate of the canonical protein synthesis pathw...

    journal_title：Molecular cancer

    pub_type： 杂志文章,评审

    doi：10.1186/s12943-019-0968-4

    authors： Chee NT,Lohse I,Brothers SP

    更新日期：2019-03-30 00:00:00

  • RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts.

    abstract：BACKGROUND:Incorrect segregation of whole chromosomes or parts of chromosome leads to aneuploidy commonly observed in cancer. The correct centrosome duplication, assuring assembly of a bipolar mitotic spindle, is essential for chromosome segregation fidelity and preventing aneuploidy. Alteration of p53 and pRb function...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-5-38

    authors： Iovino F,Lentini L,Amato A,Di Leonardo A

    更新日期：2006-09-20 00:00:00

  • Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity.

    abstract：BACKGROUND:Co-Activator Arginine Methyltransferase 1(CARM1) is an Estrogen Receptor (ER) cofactor that remodels chromatin for gene regulation via methylation of Histone3. We investigated CARM1 levels and localization across breast cancer tumors in a cohort of patients of either European or African ancestry. METHODS:We...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-12-40

    authors： Davis MB,Liu X,Wang S,Reeves J,Khramtsov A,Huo D,Olopade OI

    更新日期：2013-05-10 00:00:00

  • Overexpression of Eag1 potassium channels in clinical tumours.

    abstract：BACKGROUND:Certain types of potassium channels (known as Eag1, KCNH1, Kv10.1) are associated with the production of tumours in patients and in animals. We have now studied the expression pattern of the Eag1 channel in a large range of normal and tumour tissues from different collections utilising molecular biological a...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-5-41

    authors： Hemmerlein B,Weseloh RM,Mello de Queiroz F,Knötgen H,Sánchez A,Rubio ME,Martin S,Schliephacke T,Jenke M,Heinz-Joachim-Radzun,Stühmer W,Pardo LA

    更新日期：2006-10-05 00:00:00

  • Insulin-like growth factor-I gene therapy reverses morphologic changes and reduces hyperprolactinemia in experimental rat prolactinomas.

    abstract：BACKGROUND:The implementation of gene therapy for the treatment of pituitary tumors emerges as a promising complement to surgery and may have distinct advantages over radiotherapy for this type of tumors. Up to now, suicide gene therapy has been the main experimental approach explored to treat experimental pituitary tu...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-7-13

    authors： Console GM,Herenu CB,Camihort GA,Luna GC,Bracamonte MI,Morel GR,Goya RG

    更新日期：2008-01-25 00:00:00

  • Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma.

    abstract：:Glioblastoma (GBM) is the most aggressive type of primary brain tumours. Anti-angiogenic therapies (AAT), such as bevacizumab, have been developed to target the tumour blood supply. However, GBM presents mechanisms of escape from AAT activity, including a speculated direct effect of AAT on GBM cells. Furthermore, beva...

    journal_title：Molecular cancer

    pub_type： 信件

    doi：10.1186/s12943-018-0878-x

    authors： Simon T,Pinioti S,Schellenberger P,Rajeeve V,Wendler F,Cutillas PR,King A,Stebbing J,Giamas G

    更新日期：2018-08-31 00:00:00

  • Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines.

    abstract：BACKGROUND:Kinases downstream of growth factor receptors have been implicated in radioresistance and are, therefore, attractive targets to improve radiotherapy outcome in head and neck squamous cell carcinoma (HNSCC) patients. METHODS:An antibody-based array was used to quantify the expression levels of multiple phosp...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-12-133

    authors： Stegeman H,Kaanders JH,Verheijen MM,Peeters WJ,Wheeler DL,Iida M,Grénman R,van der Kogel AJ,Span PN,Bussink J

    更新日期：2013-11-05 00:00:00

  • IRF5 promotes the proliferation of human thyroid cancer cells.

    abstract：BACKGROUND:Interferon Regulatory Factor 5 is a transcription factor that regulates the expression of genes involved in the response to viral infection and in the stimulation of the immune system. Moreover, multiple studies have demonstrated that it negatively regulates cell growth and oncogenesis, favoring cell differe...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-11-21

    authors： Massimino M,Vigneri P,Fallica M,Fidilio A,Aloisi A,Frasca F,Manzella L

    更新日期：2012-04-16 00:00:00

  • Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.

    abstract：BACKGROUND:CD44 is considered as 'a' metastasis associated gene, despite the fact that it is an umbrella term for a group of molecules produced from a single gene by alternative splicing. However, little consideration is given to the above in the literature of colorectal carcinomas as well as other tumour types, leadin...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-11-83

    authors： Bánky B,Rásó-Barnett L,Barbai T,Tímár J,Becságh P,Rásó E

    更新日期：2012-11-14 00:00:00

  • Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy.

    abstract：:Autophagy is a highly conserved catabolic process that mediates degradation of pernicious or dysfunctional cellular components, such as invasive pathogens, senescent proteins, and organelles. It can promote or suppress tumor development, so it is a "double-edged sword" in tumors that depends on the cell and tissue typ...

    journal_title：Molecular cancer

    pub_type： 杂志文章,评审

    doi：10.1186/s12943-019-1030-2

    authors： Chen HT,Liu H,Mao MJ,Tan Y,Mo XQ,Meng XJ,Cao MT,Zhong CY,Liu Y,Shan H,Jiang GM

    更新日期：2019-05-24 00:00:00

  • Phospholipid Phosphatase 4 promotes proliferation and tumorigenesis, and activates Ca2+-permeable Cationic Channel in lung carcinoma cells.

    abstract：BACKGROUND:Phospholipid phosphatase 4 (PPAPDC1A or PLPP4) has been demonstrated to be involved in the malignant process of many cancers. The purpose of this study was to investigate the clinical significance and biological roles of PLPP4 in lung carcinoma. METHODS:PLPP4 expression was examined in 8 paired lung carcino...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-017-0717-5

    authors： Zhang X,Zhang L,Lin B,Chai X,Li R,Liao Y,Deng X,Liu Q,Yang W,Cai Y,Zhou W,Lin Z,Huang W,Zhong M,Lei F,Wu J,Yu S,Li X,Li S,Li Y,Zeng J,Long W,Ren D,Huang Y

    更新日期：2017-08-29 00:00:00